ATE443715T1 - Polypeptide aus haemophilus influenza - Google Patents

Polypeptide aus haemophilus influenza

Info

Publication number
ATE443715T1
ATE443715T1 AT01986694T AT01986694T ATE443715T1 AT E443715 T1 ATE443715 T1 AT E443715T1 AT 01986694 T AT01986694 T AT 01986694T AT 01986694 T AT01986694 T AT 01986694T AT E443715 T1 ATE443715 T1 AT E443715T1
Authority
AT
Austria
Prior art keywords
polypeptides
haemophilus influenza
basb203
prophylactic
diagnostic
Prior art date
Application number
AT01986694T
Other languages
English (en)
Inventor
Joelle Thonnard
Original Assignee
Glaxosmithkline Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog filed Critical Glaxosmithkline Biolog
Application granted granted Critical
Publication of ATE443715T1 publication Critical patent/ATE443715T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1242—Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01986694T 2000-10-13 2001-10-05 Polypeptide aus haemophilus influenza ATE443715T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0025170.2A GB0025170D0 (en) 2000-10-13 2000-10-13 Novel compounds
PCT/EP2001/011559 WO2002030960A2 (en) 2000-10-13 2001-10-05 Polypeptide from haemophilus influenza

Publications (1)

Publication Number Publication Date
ATE443715T1 true ATE443715T1 (de) 2009-10-15

Family

ID=9901254

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01986694T ATE443715T1 (de) 2000-10-13 2001-10-05 Polypeptide aus haemophilus influenza

Country Status (9)

Country Link
US (2) US7291722B2 (de)
EP (1) EP1326887B1 (de)
AT (1) ATE443715T1 (de)
AU (1) AU2002223598A1 (de)
CA (1) CA2424933A1 (de)
DE (1) DE60140006D1 (de)
ES (1) ES2333410T3 (de)
GB (1) GB0025170D0 (de)
WO (1) WO2002030960A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025170D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0025171D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds
SG10201600336RA (en) 2006-01-17 2016-02-26 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein e; pe)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123580C (en) * 1992-09-16 2005-04-26 James B. Dale Antigen of hybrid m protein and carrier for group a streptococcal vaccine
US5807978A (en) * 1995-06-07 1998-09-15 Kokolus; William J. Immunogenic peptides of prostate specific antigen
US6716433B1 (en) * 1997-09-12 2004-04-06 University Of Tennessee Research Foundation Group a streptococcal vaccines
US6036386A (en) * 1998-05-18 2000-03-14 Mcdonald; Gayle Portable golf ball washer
DE122007000087I1 (de) * 1998-10-16 2008-03-27 Glaxosmithkline Biolog Sa Adjuvanzsysteme und impfstoffe
GB0025170D0 (en) * 2000-10-13 2000-11-29 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
DE60140006D1 (de) 2009-11-05
WO2002030960A2 (en) 2002-04-18
ES2333410T3 (es) 2010-02-22
CA2424933A1 (en) 2002-04-18
US20080233123A1 (en) 2008-09-25
US20040058863A1 (en) 2004-03-25
AU2002223598A1 (en) 2002-04-22
US7291722B2 (en) 2007-11-06
WO2002030960A3 (en) 2002-11-07
EP1326887A2 (de) 2003-07-16
EP1326887B1 (de) 2009-09-23
GB0025170D0 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
ATE270332T1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
DE60140006D1 (de) Polypeptide aus haemophilus influenza
GB9809683D0 (en) Novel compounds
GB9810285D0 (en) Novel compounds
GB9812440D0 (en) Novel compounds
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
GB9918208D0 (en) Novel compounds
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
GB9918003D0 (en) Novel compounds
GB9918302D0 (en) Novel compounds
WO2002034772A3 (en) Novel compounds
WO2002060938A3 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
WO2003010195A3 (en) Novel compounds
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
DE69919693D1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
WO2002046215A3 (en) Basb221 polypeptides and polynucleotides encoding basb221 polypeptides
ATE293692T1 (de) Moraxella catarrhalis antigen basb120
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties